Croissy-Beaubourg and Montpellier, January 14, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces today its financial reporting schedule for 2016.Financial publications will be released after market close.…
11th CE marking for the Lisa Tracker® rangeComplete range of monitoring tests for inflammatory bowel disease biotherapiesCroissy-Beaubourg and Montpellier, December 14, 2015 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics…
Further validation of the value added by LISA TRACKER tests for monitoring treatments in rheumatoid arthritis patients with a loss of response Results presented at the American College of Rheumatology’s (ACR) Annual MeetingCroissy-Beaubourg, December 8,…